Literature DB >> 10812305

Depression among needle exchange program and methadone maintenance clients.

R S Brienza1, M D Stein, M Chen, A Gogineni, M Sobota, J Maksad, P Hu, J Clarke.   

Abstract

The objective of this study was to compare the prevalence of major depression in two cohorts of injection drug users, those enrolled in a Rhode Island Methadone Maintenance Treatment Program (MMTP) and those enrolled in a Rhode Island Needle Exchange Program (NEP) using cross-sectional interviews. Symptomatic and duration criteria for major depression in the last 6 months were identified using the Structured Clinical Interview for DSM-III-R (SCID). Among 528 persons interviewed, 54% of those in NEP and 42% of those in MMTP met criteria for major depression. Using multivariate logistic regression, women (odds ratio [OR] 2.5; 95% confidence interval [CI] 1.7-3.7), persons with alcohol use disorders (OR 1.7; 95% CI 1.1-2. 7), and persons without a current partner (OR 1.8; 95% CI 1.2-2.6) were more likely to be depressed controlling for age, race, education and HIV status. Persons enrolled in MMTP were less likely to be depressed (OR 0.6; 95% CI 0.4-0.8) than NEP. Higher rates of depression were found among NEP attendees than among those enrolled in MMTP. Mental health referrals should be part of the growing number of needle exchanges in the United States.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812305     DOI: 10.1016/s0740-5472(99)00084-7

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  46 in total

1.  Intravenous drug users' HIV-risk behaviors with primary/other partners.

Authors:  Cynthia Rosengard; Bradley Anderson; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2004-05       Impact factor: 3.829

Review 2.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

3.  Physician introduction to opioids for pain among patients with opioid dependence and depressive symptoms.

Authors:  Judith I Tsui; Debra S Herman; Malyna Kettavong; Daniel Alford; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2010-08-19

4.  Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.

Authors:  Michael D Stein; Mitika Kanabar; Bradley J Anderson; Anna Lembke; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2016-06-16

5.  Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment.

Authors:  Daniel Rosen; Jennifer Q Morse; Charles F Reynolds
Journal:  J Subst Abuse Treat       Date:  2010-10-30

6.  Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.

Authors:  Michael D Stein; Debra S Herman; Malyna Kettavong; Patricia A Cioe; Peter D Friedmann; Tahir Tellioglu; Bradley J Anderson
Journal:  J Subst Abuse Treat       Date:  2010-07-03

7.  The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?

Authors:  Icro Maremmani; Matteo Pacini; Pier Paolo Pani; Giulio Perugi; Joseph Deltito; Hagop Akiskal
Journal:  Ann Gen Psychiatry       Date:  2007-11-13       Impact factor: 3.455

8.  Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: a longitudinal study.

Authors:  Judith I Tsui; Bradley J Anderson; David R Strong; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2014-02-12       Impact factor: 3.829

9.  Low prefrontal perfusion linked to depression symptoms in methadone-maintained opiate-dependent patients.

Authors:  Jesse J Suh; Daniel D Langleben; Ronald N Ehrman; Jonathan G Hakun; Ze Wang; Yin Li; Samantha I Busch; Charles P O'Brien; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2008-07-31       Impact factor: 4.492

10.  Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Christopher Burke; Ken Kolodner; Robert K Brooner
Journal:  Addict Behav       Date:  2010-01-04       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.